MannKind Corporation (MNKD) was one of the Russell 2000's biggest losers for August 12 as the stock slid 12.31% to $7.48, a loss of $1.05 per share. Starting at an opening price of $8.29 a share, the stock traded between $7.22 and $8.29 over the course of the trading day. Volume was 44,214,355 shares over 89,385 trades, against an average daily volume of 10,956,399 shares and a total float of 388,615,163.
The losses send MannKind Corporation down to a market cap of $2.9 billion. In the last year, MannKind Corporation has traded between $11.48 and $3.80, and its 50-day SMA is currently $9.69 and 200-day SMA is $6.76.
The stock's P/B ratio is 188.68, and P/FCF ratio is -23.40.
For a full analysis of MannKind Corporation, check out Equities.com's E.V.A. report.
MannKind Corp is a development stage company engaged in the discovery, development, and commercialization of therapeutic products for diseases such as diabetes.
MannKind Corporation, led by CEO Alfred E. Mann, has 265 employees and is headquartered in Valencia, CA.
One of the most effective tools for tracking the market for small-cap stocks is the Russell 2000, the nation's leading small-cap index created by industry stalwart Russell Investments. Unlike the well-known Dow Jones Industrial Average (DJIA) and S&P 500, Russell's indices eschew committee selection in favor of a more objective, rules-based system for selecting index membership.
The broad-based Russell 3000, which is meant to cover the stock market as a whole, is simply the 3,000 companies with the largest market cap in the United States. The Russell 2000 is then just the bottom 2,000 companies of that index, offering a look at those small-cap companies with smaller market caps. It makes for an unbiased overview of the small-cap stocks that can help any investor get a better sense of what the market is doing and where it might be headed.